| 000 | 01657nam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025543.0 | ||
| 008 | 090317s2009 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng. | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc. | ||
| 099 | _aCai01.11.18.M.Sc.2009.Hu.R | ||
| 100 | 0 | _aHussam Mohammad Naser Aldeen | |
| 245 | 1 | 0 |
_aResults of treatment of adult Egyptian patients with CML using lmatinib mesylate / _cHussam Mohammad Naser Aldeen ; Supervised Mona Mohammad Elkassas , Raafat Mohammad Abdalfattah |
| 246 | 1 | 5 | _aنتائج استخدام عقار ايماتينيب ميسيلات في علاج اللوكيميا الميلوديه المزمنة في المرضي الكبار المصرين |
| 260 |
_aCairo : _bHussam Mohammad Naser Aldeen , _c2009 |
||
| 300 |
_a148P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
| 520 | _aChronic myeloid leukemia (CML) is a form of chronic myeloproliferative disease (CMPD) with a well-defined genetic defect known as the philadelphia (Ph) chromosome. The Ph chromosome is associated with a BCR-ABL fusion gene expressed as an oncoprotein | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBCR-ABL fusion gene | |
| 653 | 4 | _aChronic myeloid leukemia CML | |
| 653 | 4 | _aPhiladelphia (Ph) chromosome | |
| 700 | 0 |
_aMona Mohammad Elkassas , _eSupervisor |
|
| 700 | 0 |
_aRaafat Mohammad Abdalfattah , _esupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c15492 _d15492 |
||